The first cardiac bioimplant developed to treat patients with myocardial infarction, the PeriCord
When a myocardial infarction occurs, blood stops circulating and properly nourishing the heart muscle cells. The heart loses strength to beat due to the death of cells in the injured area, which have stopped receiving blood from the coronary arteries. As a result of cell death, a permanent non-contractile scar is generated, which affects the […]
What is axillary access to the aortic valve?
The growth of percutaneous aortic valve implantation (TAVI) has driven the development of minimally invasive techniques for the implantation of conventional valves. The Cardiac Surgery Service of the Germans Trias i Pujol Hospital is a benchmark in this type of intervention, which involves less aggression for the patient. “The axillary access avoids fracturing the sternum, […]
iCor – IGTP and Boehringer Ingelheim strengthen their collaboration with preclinical research
The biopharmaceutical company Boehringer Ingelheim has signed a new collaboration agreement with the Germans Trias i Pujol Research Institute (IGTP) to launch a new research project focused on evaluating the potential benefit of a new molecule in the cardiovascular-renal-metabolic axis. The alliance between both institutions is part of a strategic collaboration initiated in 2020 between […]
The Heart Area of Germans Trias, the first health center in the State to participate with a patient in the international EASY-AS study
The Heart Institute of the Germans Trias i Pujol University Hospital (iCor) has been the first hospital in Spain to include a patient in the international EASY-AS study (Asymptomatic Aortic Estenosis). The main objective of this clinical trial is to establish an early aortic valve replacement strategy in asymptomatic patients with severe aortic stenosis that […]
The knowledge and research of the Heart Institute, at the 2025 Congress of The American College of Cardiology
Three studies with the active participation of the Heart Institute of the Germans Trias i Pujol Hospital (iCor) were presented at the 2025 Congress of the American College of Cardiology, organized in Chicago (United States). Among more than 4,000 scientific research proposals, ACC 2025 included in its scientific program three research studies carried out by […]
The first VASCRAFT bioimplant successfully applied
The consortium made up of the Blood and Tissue Bank (BST), the Germans Trias i Pujol Research Institute (IGTP) and IQS Barcelona has successfully performed the first vascular graft of biological origin, known as VASCRAFT, as a therapeutic and innovative alternative for coronary bypass in patients with coronary disease. The VASCRAFT project, formed by a […]
The Germans Trias iCor implants the first Avalus Ultra prosthesis in Catalonia
The Medical Team of the Cardiac Surgery Service of the Heart Institute (iCor) of the Germans Trias i Pujol University Hospital, led by Dr. Elisabet Berastegui, has successfully completed the first implant of the Avalus Ultra prosthesis achieved in Catalonia and the second in the entire Spanish State. The Avalus Ultra prosthesis implant expands the […]
The Heart Institute (iCor) of Germans Trias, present at the Annual Congress of the Association of Acute Cardiological Care (ACVC) of the European Society of Cardiology 2025.
The Cardiology Service of the Heart Institute of the Germans Trias i Pujol University Hospital participated in the Annual Congress …
Workshop on mechanical circulatory support
The training program of the Heart Institute (iCor) of the Germans Trias held a workshop on percutaneous mechanical circulatory support last Thursday, February 27, with the collaboration of doctors from the Hemodynamics Unit, the Cardiological Acute Care Unit and the Cardiac Imaging Unit aimed at medical and nursing staff on the management and complications of […]
